YOHIMBINE HCL 2MG 2 MG
YOHIMBINE HYDROCHLORIDE : 2 MG · DIN 01954504 · ODAN LABORATORIES LTD
Health Canada status: CANCELLED POST MARKET
What is YOHIMBINE HCL 2MG?
YOHIMBINE HCL 2MG 2 MG contains YOHIMBINE HYDROCHLORIDE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 01954504, held by ODAN LABORATORIES LTD, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 19-Jul-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01954504 |
|---|---|
| Brand name | YOHIMBINE HCL 2MG |
| Generic / active ingredient | YOHIMBINE HYDROCHLORIDE : 2 MG |
| Manufacturer | ODAN LABORATORIES LTD |
| Strength | 2 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | G04BE04 YOHIMBIN |
| AHFS class | 92:92.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 19-Jul-2010 |
| Original market date | 1992-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code G04BE04 YOHIMBIN. 0 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| YOCON TABLET 5.4MG | 5.4 MG | TABLET | PALISADES PHARMACEUTICALS INC. | CANCELLED POST MARKET | DIN 00795283 |
| YOHIMBINE HCL 5.4MG | 5.4 MG | TABLET | ODAN LABORATORIES LTD | CANCELLED POST MARKET | DIN 01954342 |
| YOHIMBINE HYDROCHLORIDE TAB 2MG | 2 MG | TABLET | ODAN LABORATORIES LTD | CANCELLED POST MARKET | DIN 00885533 |
| YOHIMBINE HYDROCHLORIDE TABLETS 5.4MG | 5.4 MG | TABLET | TANTA PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02049155 |
| YOHIMBINE TAB 2MG | 2 MG | TABLET | WELCKER-LYSTER LTD., DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00206202 |
| YOHIMBINE TAB 5.4MG | 5.4 MG | TABLET | ODAN LABORATORIES LTD | CANCELLED POST MARKET | DIN 01901885 |
| YOHIMBINE TAB 6MG | 6 MG | TABLET | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | DIN 00843512 |
| YOHIMBINE-ODAN 6MG | 6 MG | TABLET | ODAN LABORATORIES LTD | CANCELLED POST MARKET | DIN 01985604 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.